Head and neck squamous cell carcinoma spheroid- and monocyte spheroid-stimulated IL-6 and monocyte chemotactic protein-1 secretion are related to TNM stage, inflammatory state and tumor macrophage density

Acta Oto-Laryngologica

Volumn 125, Issue 10, 2005, Pages 1097-1104

  Kross, Kenneth W ^a   Heimdal, John Helge ^a   Olsnes, Carla ^a   Olofsson, Jan ^a   Aarstad, Hans Jørgen ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Co culture; Macrophage; Monocyte; Neoplasms; Spheroids

Indexed keywords

CYTOKINE; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

CANCER STAGING; CLINICAL ARTICLE; COCULTURE; CONFERENCE PAPER; CYTOKINE RELEASE; EPITHELIUM CELL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FIBROBLAST; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; INFLAMMATION; INTERSTITIUM; MACROPHAGE; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN SECRETION; SPHEROID CELL; SQUAMOUS CELL CARCINOMA;

BLOOD SEDIMENTATION; CARCINOMA, SQUAMOUS CELL; CELL COUNT; CHEMOKINE CCL2; COCULTURE TECHNIQUES; HEAD AND NECK NEOPLASMS; HUMANS; INTERLEUKIN-6; MACROPHAGES; MONOCYTES; NEOPLASM STAGING; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 27144463131     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480510038031     Document Type: Conference Paper

References (29)

1. Whiteside TL, Vujanovic NL, Herberman RB. Natural killer cells and tumor therapy. Curr Top Microbiol Immunol 1998; 230:221-44.
2. Andreesen R, Hennemann B, Krause S. Adoptive immunotherapy of cancer using monocyte-derived macrophages: rationale, current status and perspectives. J Leukoc Biol 1998;64:419-26.
3. Alexandroff AB, Robins RA, Murray A, James K. Tumour immunology: false hopes-new horizons? Immunol Today 1998;19:247-50.
4. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
5. Kerrebijn JD, Balm AJ, Freeman JL, Dosch HM, Drexhage HA. Who is in control of the immune system in head and neck cancer? Crit Rev Oncol Hematol 1999;31:31-53.
6. Fidler IJ. Therapy of cancer metastasis by systemic activation of macrophages. Adv Pharmacol 1994;30:271-326.
7. Wollenberg B, Ollesch A, Maag K, Funke I, Wilmes E. Micrometastases in bone marrow of patients with cancers in the head and neck area. Laryngorhinootologie 1994;73:88-93 (in German).
8. Seljelid R. Tumour immunology: alternative perspectives. Scand J Immunol 1997;46:437-44.
9. Barton BE. IL-6: insights into novel biological activities. Clin Immunol Immunopathol 1997;85:16-20.
10. Horn F, Henze C, Heidrich K. Interleukin-6 signal transduction and lymphocyte function. Immunobiology 2000; 202:151-67.
11. Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ 2003;10:45-65.
12. Gu L, Rutledge B, Fiorillo J, Ernst C, Grewal I, Flavell R, et al. In vivo properties of monocyte chemoattractant protein-1. J Leukoc Biol 1997;62:577-80.
13. Hong SH, Ondrey FG, Avis IM, Chen Z, Loukinova E, Cavanaugh PF, et al. Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL-6: a general role for inflammation? FASEB J 2000;14: 1499-507.
14. Nishino H, Miyata M, Kitamura K. The effect of interleukin-6 on enhancing the invasiveness of head and neck cancer cells in vitro. Eur Arch Otorhinolaryngol 1998;255: 468-72.
15. Martinet N, Beck G, Bernard V, Plenat F, Vaillant P, Schooneman F, et al. Mechanism for the recruitment of macrophages to cancer site. In vivo concentration gradient of monocyte chemotactic activity. Cancer 1992;70:854-60.
16. Heimdal J-H, Aarstad HJ, Olofsson J. Monocytes secrete interleukin-6 when co-cultured in vitro with benign or malignant autologous fragment spheroids from squamous cell carcinoma patients. Scand J Immunol 2000;51:271-8.
17. Heimdal JH, Aarstad HJ, Aakvaag A, Olofsson J. T-lymphocyte function in head and neck cancer patients. Eur Arch Otorhinolaryngol 1997;254:318-22.
18. Williams MA, Rhoades CJ, Newland AC, Kelsey SM. The potential for monocyte-mediated immunotherapy during infection and malignancy. Part II. In vivo activation by exogenous cytokines and clinical applications. Leuk Lymphoma 1999;34:207-30.
19. Sica A, Saccani A, Mantovani A. Tumor-associated macrophages: a molecular perspective. Int Immunopharmacol 2002;2:1045-54.
20. Ramadori G, Christ B. Cytokines and the hepatic acute phase response. Semin Liver Dis 1999;19(2):141-55.
21. Heimdal J-H, Olsnes C, Olofsson J, Aarstad HJ. Macrophage secretion of mcp-1 in co-culture with autologous malignant and benign control fragment spheroids. Cancer Immunol Immunother 2001;50:300-6.
22. Varfolomeev EE, Ashkenazi A. Tumor Necrosis factor: an apoptotic JuNKie? Cell 2004;116(49):491-7.
23. Boyum A. Isolation of human blood monocytes with Nycodenz, a new non-ionic iodinated gradient medium. Scand J Immunol 1983;17:429-36.
24. Olsnes C, Heimdal JH, Kross K, Olofsson J, Aarstad HJ. Mechanisms for monocyte activation in co-culture with autologous tumor spheroids. Cell Immunol 2002;219:11-21.
25. Silzie T, Kreut M, Dobler MA, Brockhoff G, Kneuchel R, Kunz-Schughart LA. Tumor-associated fibroblasts recruit blood monocytes into tumor tissue. Eur J Immunolog 2003; 33(5):1311-20.
26. Hensler T, Hecker H, Heeg K, Heidecke CD, Bartels H, Barthlen W, et al. Distinct mechanisms of immunosuppression as a consequence of major surgery. Infect Immun 1997; 65:2283-91.
27. Heimdal J-H, Aarstad HJ, Klementsen B, Olofsson J. Ex vivo interleukin (IL)-1 beta, IL-6, IL-12 and tumor necrosis factor-alpha responsiveness with monocytes from patients with head and neck carcinoma. Eur Arch Otorhinolaryngol 1999;256:250-6.
28. Olsnes C, Heimdal JH, Kross K, Olofsson J, Aarstad HJ. Autologous HNSCC tumors stimulate monocyte mcp-1-generated secretion via lectin-like receptors and CD14 epitope. Eur Arch Otorhinolaryngol 2005; In press.
29. Ohta M, Kitadai Y, Tanaka S, Yoshihara M, Yasui W, Mukadai N, et al. Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas. Int J Cancer 2002;102:220-2.